首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: Long-term outcome
【24h】

Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: Long-term outcome

机译:复发性或转移性少位骨盆外癌的手术和术中电子放疗:长期结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate the feasibility and long-term outcome of surgery combined with intraoperative electron radiotherapy (IOERT) as rescue treatment in patients with recurrent and/or metastatic oligotopic extrapelvic cancer. Methods and materials: From April 1996 to April 2010, we treated 28 patients using 34 IOERT procedures. The main histopathology findings were adenocarcinoma (39%) and squamous cell carcinoma (29%). The original cancer sites were gynecologic (67%), urologic (14%) and colorectal (14%). The location of recurrence was the para-aortic region in 53.5% of patients. Results: Median follow-up was 39 months (1-84 months), during which time 14% of patients experienced local recurrence and 53.5% developed distant metastasis. Overall survival at 2 and 5 years was 57% and 35% respectively. At the time of the analysis, 13 patients were alive, 6 for more than 55 months of follow-up. Local control was not significantly affected by the following histopathologic characteristics of the resected surgical specimen: number of fragments submitted for pathology study (1 to >6), maximal tumor dimension (≤2 to ≥6 cm), rate of involved nodes (0-100%) and involved resection margin (local recurrence 23% vs 7%; p = 0.21). Local recurrence was significantly affected by microscopic cancer in more than 50% of specimen fragments (38% vs 9%, p = 0.02). Conclusions: IOERT for recurrence of oligotopic extrapelvic cancer incresead long-term survival in patients with controlled cancer and appears to compensate for some adverse prognostic features in local control. Individualized treatment strategies for this heterogeneous category of patients with recurrent cancer will make it possible to optimize results.
机译:目的:评估术中电子放射疗法(IOERT)联合手术治疗复发和/或转移性少位骨盆外癌患者的可行性和长期结果。方法和材料:从1996年4月至2010年4月,我们采用34种IOERT程序治疗了28例患者。主要的组织病理学发现是腺癌(39%)和鳞状细胞癌(29%)。最初的癌症部位是妇科(67%),泌尿科(14%)和结直肠癌(14%)。复发的位置是53.5%的患者的主动脉旁区域。结果:中位随访时间为39个月(1-84个月),在此期间14%的患者经历了局部复发,而53.5%的患者发生了远处转移。 2年和5年总生存率分别为57%和35%。在分析时,有13名患者还活着,其中6名接受了55个月以上的随访。切除的手术标本的以下组织病理学特征未显着影响局部控制:提交病理研究的碎片数量(1至> 6),最大肿瘤尺寸(≤2至≥6cm),累及结节率(0- 100%)并涉及切除切缘(局部复发23%vs 7%; p = 0.21)。显微镜检查发现,超过50%的标本碎片显着影响了局部复发(38%比9%,p = 0.02)。结论:IOERT用于盆腔寡位癌的复发增加了可控制癌症患者的长期生存率,并且似乎可以弥补局部控制中的一些不良预后特征。针对这种类型的复发性癌症患者的个性化治疗策略将有可能优化结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号